From the discussion in the section above on the steady-state model, the reduction of the concentration of oxytocin by 62% would result in a new lower baseline concentration of oxytocin for as long as the increased permeability of the blood-brain barrier resulting from the MAST Immune System disease existed. The gene discussed is OXT; the disease is immune system disorder.